GREAT VALLEY ADVISOR GROUP, INC.

Position in SMMT — Summit Therapeutics Inc.

CIK 1769897 WILMINGTON, DE

Position in SMMT

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$486,134

+$37,691 QoQ

Shares Held

25,640

0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

GREAT VALLEY ADVISOR GROUP, INC. holds $4,433,787 across 10 Biotechnology names. SMMT ranks #4 (11.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,540	$1,854,835
2	CELC	Celcuity Inc.	5,480	$625,487
3	INCY	Incyte Corp	5,394	$507,683
4	SMMT	Summit Therapeutics Inc. This page	25,640	$486,134
5	VRTX	Vertex Pharmaceuticals Inc / Ma	900	$401,886
6	JAZZ	Jazz Pharmaceuticals plc	1,066	$201,527
7	EYPT	EyePoint, Inc.	10,750	$138,567
8	IMRX	Immuneering Corp	21,120	$111,302

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$486,134	25,640	0.0%	Shares	Sole	2026-05-11
2025-12-31	$448,443	25,640	-0.1%	Shares	Sole	2026-02-12
2025-09-30	$530,404	25,673	+2.0%	Shares	Sole	2025-11-14
2025-06-30	$535,681	25,173	+0.2%	Shares	Sole	2025-08-14
2025-03-31	$484,815	25,133	+0.1%	Shares	Sole	2025-05-08
2024-12-31	$447,927	25,101	+0.4%	Shares	Sole	2025-02-24
2024-09-30	$547,500	25,000	-26.5%	Shares	Sole	2024-11-12
2024-06-30	$265,379	34,023	0.0%	Shares	Sole	2024-07-16
2024-03-31	$140,855	34,023	0.0%	Shares	Sole	2024-05-06
2023-12-31	$88,800	34,023	0.0%	Shares	Sole	2024-02-06
2023-09-30	$63,623	34,023	0.0%	Shares	Sole	2023-11-07
2023-06-30	$85,397	34,023	0.0%	Shares	Sole	2023-08-10
2023-03-31	$59,540	34,023	—	Shares	Sole	2023-05-03
No filing history on record for this holder in this stock.